Search

everythinglearnresearchcommunity

for

Search:↓

A woman with advanced eye cancer went into complete remission using a combination of immunotherapy and topical treatments.

Natural compounds, especially Withaferin-A, may help treat post-COVID-19 complications, but some may have side effects.

Pantethine may boost the immune system's ability to fight sarcoma.

C-scores can help predict gain-of-function and loss-of-function mutations.

The chitosan-peptide system helps cartilage regeneration using fat-derived cells.

Cell adhesion molecules are important in the development of certain skin diseases.

Proper skin toxicity management in chemotherapy is key to continuing treatment and keeping patient quality of life high.

Aptamin C® enhances vitamin C's antioxidant effects, benefiting skin by reducing oxidative stress and inflammation.

Monoclonal antibodies LT-1, LT-2, and LT-7 help diagnose certain blood cancers.

Hair follicles may help teach the immune system to tolerate new self-antigens, but this can sometimes cause hair loss.

Smaller particles of the drug carrier penetrated skin better, with 300 nm size being best for targeting hair follicles.

Manage side effects of hepatitis C treatment with dose changes and medications, which may improve patient adherence and treatment success.

Modified β-catenin causes different effects in hair and skin cells, leading to cysts or tumors.

Baricitinib improved platelet counts and alopecia in a 16-year-old with chronic immune thrombocytopenia.

Enzyme replacement therapy improved multiple symptoms of homocystinuria in mice.

Polycaprolactone and barium titanate composites show promise for use in biomedical applications.

A specific DNA sequence caused hair loss in male mice by activating immune cells and increasing a certain immune signal.

Cetirizine-loaded gel may effectively promote hair growth in alopecia.

Tocilizumab therapy may cause skin and hair conditions like halo naevi, vitiligo, and alopecia areata.

The treatment was effective for advanced non-Hodgkin's lymphomas.

Connubial contact dermatitis is often missed, making treatment harder.

Certain cancer drugs interact with skin bacteria to cause acne-like rashes.

Keratinocytes can reduce the survival of certain melanoma cells, suggesting new therapy paths.

New findings suggest targeting IL-23 could treat psoriasis, skin cells can adapt to new roles, direct conversion of skin cells to blood cells may aid cell therapy, removing certain tumor cells could boost cancer immunotherapy, and melanoma may have many tumorigenic cells, not just cancer stem cells.

Cetuximab can cause unusual hair growth and hair loss.

The new skin model can predict how chemicals might cause skin allergies.

Nonimmunosuppressive cyclosporines might treat skin diseases by affecting cell growth.

KRTAP2-3 could help predict cancer recurrence by identifying specific cancer cells.